The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
暂无分享,去创建一个
[1] S. Morjaria,et al. Commensal microbes provide first line defense against Listeria monocytogenes infection , 2017, The Journal of experimental medicine.
[2] E. Pamer,et al. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. , 2017, Cell host & microbe.
[3] S. Abramson,et al. Short- and long-term effects of oral vancomycin on the human intestinal microbiota , 2016, The Journal of antimicrobial chemotherapy.
[4] L. Jia,et al. Advances in antibiotic therapy in the critically ill , 2016, Critical Care.
[5] R. Edwards,et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut , 2016, Nature.
[6] Peter T. McKenney,et al. Clostridium difficile colitis: pathogenesis and host defence , 2016, Nature Reviews Microbiology.
[7] Y. Taur,et al. Microbiome mediation of infections in the cancer setting , 2016, Genome Medicine.
[8] N. Geva-Zatorsky,et al. Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species , 2016, Proceedings of the National Academy of Sciences.
[9] C. Buffie,et al. TLR-7 activation enhances IL-22–mediated colonization resistance against vancomycin-resistant enterococcus , 2016, Science Translational Medicine.
[10] L. Comstock,et al. Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements , 2016, BMC Genomics.
[11] I. Amit,et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.
[12] Nora C. Toussaint,et al. Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole. , 2015, The Journal of infectious diseases.
[13] Pavlos Bousounis,et al. Bacteriocin production augments niche competition by enterococci in the mammalian GI tract , 2015, Nature.
[14] Na-Ri Shin,et al. Proteobacteria: microbial signature of dysbiosis in gut microbiota. , 2015, Trends in biotechnology.
[15] K. Manova,et al. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae , 2015, PLoS pathogens.
[16] R. P. Ross,et al. The sactibiotic subclass of bacteriocins: an update. , 2015, Current protein & peptide science.
[17] E. Pamer,et al. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. , 2015, Cell host & microbe.
[18] Y. Taur,et al. Role of intestinal microbiota in transplantation outcomes. , 2015, Best practice & research. Clinical haematology.
[19] B. Weimer,et al. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. , 2014, Cell host & microbe.
[20] Peter Cimermancic,et al. A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics , 2014, Cell.
[21] W. D. de Vos,et al. The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.
[22] J. Salojärvi,et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men , 2014, The ISME Journal.
[23] S. B. Peterson,et al. Type VI secretion system effectors: poisons with a purpose , 2014, Nature Reviews Microbiology.
[24] E. Pamer,et al. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns , 2014, Mucosal Immunology.
[25] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[26] Michael Grabe,et al. Antibacterial membrane attack by a pore-forming intestinal C-type lectin , 2013, Nature.
[27] C. Buffie,et al. Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.
[28] M. Icaza-Chávez,et al. Gut microbiota in health and disease , 2013 .
[29] B. Weimer,et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens , 2013, Nature.
[30] A. Gasbarrini,et al. Commensal Clostridia: leading players in the maintenance of gut homeostasis , 2013, Gut Pathogens.
[31] W. Garrett,et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.
[32] Y. Taur,et al. The intestinal microbiota and susceptibility to infection in immunocompromised patients , 2013, Current opinion in infectious diseases.
[33] Gabriel Núñez,et al. Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.
[34] T. Buckley,et al. Antibiotic Administration Routes Significantly Influence the Levels of Antibiotic Resistance in Gut Microbiota , 2013, Antimicrobial Agents and Chemotherapy.
[35] Ajay S. Gulati,et al. Mouse Paneth cell antimicrobial function is independent of Nod2 , 2013, Gut.
[36] I. Martínez,et al. Gut microbiome composition is linked to whole grain-induced immunological improvements , 2012, The ISME Journal.
[37] R. P. Ross,et al. Bacteriocins — a viable alternative to antibiotics? , 2012, Nature Reviews Microbiology.
[38] E. Cascales,et al. Imaging type VI secretion-mediated bacterial killing. , 2013, Cell reports.
[39] E. Zoetendal,et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.
[40] Paul S. Cohen,et al. Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine , 2013, PloS one.
[41] Nora C. Toussaint,et al. Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization , 2013, Infection and Immunity.
[42] S. Sonis,et al. Pathobiology of Cancer Regimen-Related Toxicities , 2013, Springer New York.
[43] E. Cascales,et al. Promoter Swapping Unveils the Role of the Citrobacter rodentium CTS1 Type VI Secretion System in Interbacterial Competition , 2012, Applied and Environmental Microbiology.
[44] N. Socci,et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] Taane G. Clark,et al. Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice , 2012, PLoS pathogens.
[46] R. Knight,et al. Diversity, stability and resilience of the human gut microbiota , 2012, Nature.
[47] Vincent B. Young,et al. Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae , 2012, Infection and Immunity.
[48] R. Porcher,et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[49] Fernanda C. Lessa,et al. Current Status of Clostridium difficile Infection Epidemiology , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] E. Pamer,et al. Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis , 2012, Infection and Immunity.
[51] G. Núñez,et al. Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota , 2012, Science.
[52] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[53] E. Martens,et al. How glycan metabolism shapes the human gut microbiota , 2012, Nature Reviews Microbiology.
[54] C. Huff,et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] G. Jensen,et al. Type VI secretion requires a dynamic contractile phage tail-like structure , 2012, Nature.
[56] T. Hohl,et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. , 2012, Immunity.
[57] Michael A Fischbach,et al. Eating for two: how metabolism establishes interspecies interactions in the gut. , 2011, Cell host & microbe.
[58] A. Viale,et al. Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis , 2011, Infection and Immunity.
[59] M. Bäckström,et al. Composition and functional role of the mucus layers in the intestine , 2011, Cellular and Molecular Life Sciences.
[60] J. Walter,et al. The human gut microbiome: ecology and recent evolutionary changes. , 2011, Annual review of microbiology.
[61] Waldemar Vollmer,et al. Type VI secretion delivers bacteriolytic effectors to target cells , 2011, Nature.
[62] G. Michel,et al. Environmental and Gut Bacteroidetes: The Food Connection , 2011, Front. Microbio..
[63] G. Nava,et al. Spatial organization of intestinal microbiota in the mouse ascending colon , 2011, The ISME Journal.
[64] K. Sepkowitz,et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] J. Parkhill,et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.
[66] A. Velcich,et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[67] E. Pamer,et al. Toll-Like Receptor 5 Stimulation Protects Mice from Acute Clostridium difficile Colitis , 2011, Infection and Immunity.
[68] G. Alangaden,et al. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation , 2011, Clinical transplantation.
[69] N. Socci,et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.
[70] G. Papanicolaou,et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[71] C. Hill,et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon , 2010, Proceedings of the National Academy of Sciences.
[72] John W. Froehlich,et al. Consumption of human milk oligosaccharides by gut-related microbes. , 2010, Journal of agricultural and food chemistry.
[73] W. Tissing,et al. The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis , 2010, PLoS pathogens.
[74] J. Vederas,et al. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile , 2010, Proceedings of the National Academy of Sciences.
[75] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[76] B. Currie,et al. Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation , 2010, Infection Control & Hospital Epidemiology.
[77] A. Macpherson,et al. Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.
[78] Richard A Flavell,et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. , 2010, The Journal of infectious diseases.
[79] G. Eliopoulos,et al. The Sanford guide to antimicrobial therapy , 2010 .
[80] M. Levison,et al. Pharmacokinetics and pharmacodynamics of antibacterial agents. , 2009, Infectious disease clinics of North America.
[81] S. Rebuffat,et al. Isolation and Characterization of Two Members of the Siderophore-Microcin Family, Microcins M and H47 , 2009, Antimicrobial Agents and Chemotherapy.
[82] M. Pasparakis,et al. Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases , 2009, Nature Reviews Immunology.
[83] Christophe Caron,et al. Towards the human intestinal microbiota phylogenetic core. , 2009, Environmental microbiology.
[84] Tomas Hrncir,et al. Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.
[85] Cynthia L Sears,et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.
[86] J. Jiménez,et al. Comparative genomic analysis uncovers 3 novel loci encoding type six secretion systems differentially distributed in Salmonella serotypes , 2009, BMC Genomics.
[87] Mark H. Wilcox,et al. Clostridium difficile infection: new developments in epidemiology and pathogenesis , 2009, Nature Reviews Microbiology.
[88] C. Sears. Enterotoxigenic Bacteroides fragilis: a Rogue among Symbiotes , 2009, Clinical Microbiology Reviews.
[89] J. M. Sauder,et al. Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin , 2009, Proceedings of the National Academy of Sciences.
[90] Inka Brockhausen,et al. O-GalNAc Glycans , 2009 .
[91] J. Gordon,et al. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. , 2008, Cell host & microbe.
[92] Ronald P. DeMatteo,et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits , 2008, Nature.
[93] M. Havaux,et al. A large gene cluster encoding peptide synthetases and polyketide synthases is involved in production of siderophores and oxidative stress response in the cyanobacterium Anabaena sp. strain PCC 7120. , 2008, Environmental microbiology.
[94] M. Karin,et al. Opposing functions of IKKβ during acute and chronic intestinal inflammation , 2008, Proceedings of the National Academy of Sciences.
[95] Christopher T Walsh,et al. Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form "trojan horse" antibiotics. , 2008, Biochemistry.
[96] J. Sha,et al. Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila. , 2008, Microbial pathogenesis.
[97] A. Sonenshein,et al. Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores , 2008, Journal of bacteriology.
[98] D. Archambault,et al. Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant Enterococci , 2008, Applied and Environmental Microbiology.
[99] D. Antonopoulos,et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.
[100] Carlene A. Muto,et al. Antimicrobial-associated risk factors for Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[101] Paul S. Cohen,et al. Comparison of Carbon Nutrition for Pathogenic and Commensal Escherichia coli Strains in the Mouse Intestine , 2008, Infection and Immunity.
[102] M. Lacroix,et al. Purification and identification of the pediocin produced by Pediococcus acidilactici MM33, a new human intestinal strain , 2007, Journal of applied microbiology.
[103] Hiroshi Mori,et al. Comparative Metagenomics Revealed Commonly Enriched Gene Sets in Human Gut Microbiomes , 2007, DNA research : an international journal for rapid publication of reports on genes and genomes.
[104] Hannah M. Wexler,et al. Bacteroides: the Good, the Bad, and the Nitty-Gritty , 2007, Clinical Microbiology Reviews.
[105] G. Plitas,et al. MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection , 2007, The Journal of experimental medicine.
[106] G. Zuccotti,et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[107] Y. Ben-Neriah,et al. Epithelial NF-κB maintains host gut microflora homeostasis , 2007, Nature Immunology.
[108] C. Hill,et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 , 2007, Proceedings of the National Academy of Sciences.
[109] D. Archambault,et al. Partial characterization of bacteriocins produced by human Lactococcus lactis and Pediococccus acidilactici isolates , 2007, Journal of applied microbiology.
[110] Y. Ben-Neriah,et al. Epithelial NF-kappaB maintains host gut microflora homeostasis. , 2007, Nature immunology.
[111] S. Mazmanian,et al. The love–hate relationship between bacterial polysaccharides and the host immune system , 2006, Nature Reviews Immunology.
[112] L. Hooper,et al. Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.
[113] Ruslan Medzhitov,et al. Role of toll-like receptors in spontaneous commensal-dependent colitis. , 2006, Immunity.
[114] M. Pop,et al. Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.
[115] J. Parkhill,et al. Multireplicon genome architecture of Lactobacillus salivarius. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[116] Hening Lin,et al. How pathogenic bacteria evade mammalian sabotage in the battle for iron , 2006, Nature chemical biology.
[117] Dae-Joong Kang,et al. Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.
[118] V. Gonçalves,et al. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[119] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[120] C. Matuchansky,et al. Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits , 2005, Alimentary pharmacology & therapeutics.
[121] M. Selsted,et al. Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.
[122] G. Papanicolaou,et al. Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients , 2005, Transplant infectious disease : an official journal of the Transplantation Society.
[123] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[124] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[125] Yanping Wang,et al. Human intestinal bacteria as reservoirs for antibiotic resistance genes. , 2004, Trends in microbiology.
[126] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[127] S. Sonis. The pathobiology of mucositis , 2004, Nature Reviews Cancer.
[128] E. Vimr,et al. Diversity of Microbial Sialic Acid Metabolism , 2004, Microbiology and Molecular Biology Reviews.
[129] W. Kenealy,et al. Studies on the substrate range of Clostridium kluyveri; the use of propanol and succinate , 1985, Archives of Microbiology.
[130] K. Hantke,et al. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. , 2003, Microbiology.
[131] Jeffrey I. Gordon,et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.
[132] S. Normark,et al. Germ-free and Colonized Mice Generate the Same Products from Enteric Prodefensins* , 2000, The Journal of Biological Chemistry.
[133] D. Milligan,et al. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.
[134] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[135] J. K. Collins,et al. Selection of Probiotic Strains for Human Applications , 1998 .
[136] D. Gerding,et al. Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] K. Tanimoto,et al. Cloning and genetic and sequence analyses of the bacteriocin 21 determinant encoded on the Enterococcus faecalis pheromone-responsive conjugative plasmid pPD1 , 1997, Journal of bacteriology.
[138] P. Lawson,et al. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. , 1994, International journal of systematic bacteriology.
[139] A. Brown,et al. The changing epidemiology of infections at cancer hospitals. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[140] W. Kenealy,et al. Dehydrogenases involved in the conversion of succinate to 4-hydroxybutanoate by Clostridium kluyveri , 1993, Applied and environmental microbiology.
[141] J. Rask-Madsen,et al. BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.
[142] M. Tvede,et al. Bacteriotherapy for chronic relapsing Clostridium difficile in six patients , 1989 .
[143] D. van der Waaij,et al. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. , 1971 .
[144] D. van der Waaij,et al. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice , 1971, Journal of Hygiene.
[145] R. Curtiss,et al. Genetic Exchange Between Escherichia coli Strains in the Mouse Intestine , 1970, Journal of bacteriology.
[146] M. Bohnhoff,et al. RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION , 1964, The Journal of experimental medicine.
[147] M. Bohnhoff,et al. Effect of Streptomycin on Susceptibility of Intestinal Tract to Experimental Salmonella Infection.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.